What You Should Know:
– UltraSight, a leading developer of AI-powered cardiac ultrasound solutions, announced today a strategic partnership with SELVAS Healthcare, a Korean-based global digital healthcare company.
– The collaboration marks the launch of UltraSight’s…
Continue Reading
Experience the forefront of ultrasound technology with Sonosite Voice Assist. This groundbreaking feature, compatible with Sonosite PX and Sonosite LX systems, empowers proceduralists to operate ultrasound equipment hands-free during sterile procedures. Activated with a…
Continue Reading
Headquartered in Scottsdale, Arizona, SimonMed is one of the largest outpatient medical imaging providers and radiology practices in the United States. It covers 10 states with more than 150 locations and more than 200…
Continue Reading
What You Should Know:
– FUJIFILM Sonosite Inc., the leader in point-of-care ultrasound (POCUS) solutions, has unveiled a game-changer for healthcare professionals: Sonosite Voice Assist.
– The innovative feature allows doctors to control their Sonosite PX…
Continue Reading
What You Should Know:
– Pediatrix Medical Group, a provider of specialized healthcare for women, children, and babies in the U.S., is making waves by deploying Sonio’s AI-powered prenatal care solution.
– The innovative technology promises…
Continue Reading
A groundbreaking deep learning model has emerged as a beacon of hope in the fight against rheumatic heart disease (RHD) among children. Developed by researchers at Children’s National Hospital, this innovative tool utilizes artificial…
Continue Reading
Clarius Mobile Health’s CE Mark certification for the PAL HD3 wireless handheld whole-body ultrasound scanner marks a groundbreaking advancement. With a dual-array design and compatibility with iOS and Android devices, this compact device delivers…
Continue Reading
News
Nvidia founder and CEO Jensen Huang tells attendees of the J.P. Morgan Healthcare Conference that he expects drug design to move nearly completely to AI systems. He also predicts that medical devices such as…
Continue Reading
BioTraceIO by Techsomed secures FDA approval, revolutionizing liver ablation. Integrating AI and ultrasound imaging eliminates uncertainties in thermal ablation therapy. This breakthrough addresses complications in existing methods (like radiofrequency and microwave ablation) for inoperable…
Continue Reading
The U.S. Food and Drug Administration gave De Novo clearance to Techsomed’s BioTraceIO, which leverages a computational algorithm to analyze ultrasound images captured during liver ablation treatment for use with its artificial intelligence-powered ablation treatment…
Continue Reading
